AraƱador, Jerry A.
HRN: 24-48-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2024
CEFTRIAXONE 1G (VIAL)
02/06/2024
02/13/2024
IV
2g
Q24
Fracture Close Completely M/3rd Radius R Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes